▲ +27.65% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Rubius Therapeutics in the last 3 months. The average price target is $13.25, with a high forecast of $28.00 and a low forecast of $4.00. The average price target represents a 27.65% upside from the last price of $10.38.
The current consensus among 5 polled investment analysts is to hold stock in Rubius Therapeutics. This rating has held steady since September 2019, when it changed from a Buy consensus rating.